Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

Interaction of St John's wort (Hypericum perforatum) with clozapine.

Van Strater AC, Bogers JP.

Int Clin Psychopharmacol. 2012 Mar;27(2):121-4. doi: 10.1097/YIC.0b013e32834e8afd.

PMID:
22113252
2.

Pharmacokinetic interactions of drugs with St John's wort.

Zhou S, Chan E, Pan SQ, Huang M, Lee EJ.

J Psychopharmacol. 2004 Jun;18(2):262-76. Review.

PMID:
15260917
3.

The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).

Markowitz JS, DeVane CL.

Psychopharmacol Bull. 2001 Winter;35(1):53-64. Review.

PMID:
12397870
4.

Drug interactions with St John's wort : mechanisms and clinical implications.

Mannel M.

Drug Saf. 2004;27(11):773-97. Review.

PMID:
15350151
5.

The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.

Wang Z, Gorski JC, Hamman MA, Huang SM, Lesko LJ, Hall SD.

Clin Pharmacol Ther. 2001 Oct;70(4):317-26.

PMID:
11673747
6.

St John's wort (Hypericum perforatum) in major depression.

Shelton RC.

J Clin Psychiatry. 2009;70 Suppl 5:23-7. doi: 10.4088/JCP.8157su1c.05. Review.

7.

St John's wort: a hidden risk for transplant patients.

Turton-Weeks SM, Barone GW, Gurley BJ, Ketel BL, Lightfoot ML, Abul-Ezz SR.

Prog Transplant. 2001 Jun;11(2):116-20.

PMID:
11871046
8.

Effects of St. John's wort supplementation on ibuprofen pharmacokinetics.

Bell EC, Ravis WR, Lloyd KB, Stokes TJ.

Ann Pharmacother. 2007 Feb;41(2):229-34. Epub 2007 Feb 6.

PMID:
17284505
9.
10.

Safety and efficacy of St. John's wort (hypericum) during pregnancy and lactation.

Dugoua JJ, Mills E, Perri D, Koren G.

Can J Clin Pharmacol. 2006 Fall;13(3):e268-76. Epub 2006 Nov 3. Review.

PMID:
17085775
11.

St John's wort and depression: slight efficacy at best, many drug interactions.

[No authors listed]

Prescrire Int. 2004 Oct;13(73):187-92.

PMID:
15499702
12.

St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4.

Dürr D, Stieger B, Kullak-Ublick GA, Rentsch KM, Steinert HC, Meier PJ, Fattinger K.

Clin Pharmacol Ther. 2000 Dec;68(6):598-604.

PMID:
11180019
13.

[Phytotherapy threats with emphasis on St. John's wort medicines].

Sienkiewicz J, Czarnik-Matusewicz H, Wiela-Hojeńska A.

Pol Merkur Lekarski. 2013 Nov;35(209):309-12. Review. Polish.

PMID:
24575655
14.

Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide.

Xu H, Williams KM, Liauw WS, Murray M, Day RO, McLachlan AJ.

Br J Pharmacol. 2008 Apr;153(7):1579-86. doi: 10.1038/sj.bjp.0707685. Epub 2008 Jan 21.

15.

The effect of St John's wort (hypericum perforatum) on cytochrome p450 1a2 activity in perfused rat liver.

Dostalek M, Pistovcakova J, Jurica J, Sulcova A, Tomandl J.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Sep;155(3):253-7. doi: 10.5507/bp.2011.047.

16.

Effect of St. John's wort supplementation on the pharmacokinetics of bupropion in healthy male Chinese volunteers.

Lei HP, Yu XY, Xie HT, Li HH, Fan L, Dai LL, Chen Y, Zhou HH.

Xenobiotica. 2010 Apr;40(4):275-81. doi: 10.3109/00498250903509383.

PMID:
20102294
17.

The interaction between St John's wort and an oral contraceptive.

Hall SD, Wang Z, Huang SM, Hamman MA, Vasavada N, Adigun AQ, Hilligoss JK, Miller M, Gorski JC.

Clin Pharmacol Ther. 2003 Dec;74(6):525-35.

PMID:
14663455
18.

Potential for interaction of kava and St. John's wort with drugs.

Singh YN.

J Ethnopharmacol. 2005 Aug 22;100(1-2):108-13. Review.

PMID:
16005588
19.

St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.

Barnes J, Anderson LA, Phillipson JD.

J Pharm Pharmacol. 2001 May;53(5):583-600. Review.

PMID:
11370698
20.

St. John's wort and depression: efficacy, safety and tolerability-an update.

Bilia AR, Gallori S, Vincieri FF.

Life Sci. 2002 May 17;70(26):3077-96. Review.

PMID:
12008092

Supplemental Content

Support Center